Carmell Therapeutics Correlations

Stocks . USA . 
Stock . Carmell Therapeutics
CTCX Stock   0.28  0.02  7.69%   
The current 90-days correlation between Carmell Therapeutics and ZyVersa Therapeutics is -0.01 (i.e., Good diversification). The correlation of Carmell Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Carmell Therapeutics Correlation With Market

Weak diversification

The correlation between Carmell Therapeutics and DJI is 0.37 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Carmell Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Carmell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Carmell Stock please use our How to Invest in Carmell Therapeutics guide.

Moving together with Carmell Stock

  0.8VALN Valneva SE ADRPairCorr
  0.61DRMA Dermata TherapeuticsPairCorr
  0.65DRRX DurectPairCorr
  0.77DTIL Precision BioSciencesPairCorr
  0.64VINC Vincerx PharmaPairCorr
  0.63VIRX Viracta TherapeuticsPairCorr
  0.61VRAX Virax Biolabs GroupPairCorr
  0.81VRCA Verrica Pharmaceuticals Buyout TrendPairCorr
  0.75VTGN VistaGen TherapeuticsPairCorr

Moving against Carmell Stock

  0.79VERA Vera TherapeuticsPairCorr
  0.71VCYT VeracytePairCorr
  0.57DVAX Dynavax TechnologiesPairCorr
  0.56SABSW SAB BiotherapeuticsPairCorr
  0.5DRUG Bright Minds BiosciencesPairCorr
  0.44DSGN Design TherapeuticsPairCorr
  0.37VCEL Vericel Corp OrdPairCorr
  0.35DMAC DiaMedica TherapeuticsPairCorr
  0.72VSTM Verastem Upward RallyPairCorr
  0.69VRNA Verona Pharma PLCPairCorr
  0.67VYNE Vyne TherapeuticsPairCorr
  0.64ELTX Elicio TherapeuticsPairCorr
  0.61ELDN Eledon PharmaceuticalsPairCorr
  0.5VTRS ViatrisPairCorr
  0.44VRDN Viridian TherapeuticsPairCorr
  0.42ENSC Ensysce BiosciencesPairCorr
  0.35ELVN Enliven TherapeuticsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
VRAX
+ 0.91
ALLR
BDRX
+ 0.91
ALLR
PALI
+ 0.89
SONN
BDRX
+ 0.88
VRAX
PALI
+ 0.86
ZVSA
IMMX
+ 0.85
VRAX
  
High negative correlations   
UNCY
- 0.81
ZVSA
UNCY
- 0.75
PALI
UNCY
- 0.66
SONN
UNCY
- 0.63
ALLR
UNCY
- 0.6
BDRX
UNCY
- 0.46
VRAX

Risk-Adjusted Indicators

There is a big difference between Carmell Stock performing well and Carmell Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Carmell Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ZVSA  4.03 (0.93) 0.00  0.56  0.00 
 0.00 
 7.57 
(9.60)
 78.93 
SONN  4.77 (0.98) 0.00  1.80  0.00 
 0.00 
 12.31 
(9.79)
 37.58 
REVB  3.68 (0.72) 0.00 (0.25) 0.00 
 0.00 
 8.97 
(7.83)
 34.52 
QNRX  6.04  0.27  0.04  0.29  6.66 
(8.76)
 17.65 
(9.68)
 74.46 
ALLR  5.02 (2.09) 0.00 (1.87) 0.00 
 0.00 
 10.85 
(16.11)
 41.48 
VRAX  5.67 (0.89) 0.00  2.19  0.00 
 0.00 
 9.65 
(12.90)
 61.28 
BDRX  6.70 (1.41) 0.00 (0.33) 0.00 
 0.00 
 11.91 
(17.24)
 97.78 
PALI  3.48 (0.33) 0.00  0.54  0.00 
 0.00 
 5.97 
(8.55)
 24.25 
UNCY  4.28  0.93  0.17  0.69  4.33 
(5.53)
 10.26 
(7.41)
 29.22 
IMMX  4.25 (0.12)(0.02) 0.01  4.55 
(5.41)
 9.38 
(8.22)
 32.68 

Carmell Therapeutics Corporate Executives

Elected by the shareholders, the Carmell Therapeutics' board of directors comprises two types of representatives: Carmell Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Carmell. The board's role is to monitor Carmell Therapeutics' management team and ensure that shareholders' interests are well served. Carmell Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Carmell Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
James MDFounderProfile
Lee WeissFounderProfile
Phil CampbellFounder OfficerProfile
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY